FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2048201822> ?p ?o ?g. }

• W2048201822 endingPage "33" @default.
• W2048201822 startingPage "27" @default.
• W2048201822 abstract "BackgroundInfection with the human immunodeficiency virus (HIV) is associated both with infections of the central nervous system and with neurological deficits due to direct effects of the neurotropic virus. Seizures and epilepsy are not rare among HIV-infected patients. We investigated the frequency of acute seizures and epilepsy of patients in different stages of HIV infection. In addition, we compared the characteristics of patients who experienced provoked seizures only with those of patients who developed epilepsy.MethodsThe database of the Department of Neurology, University of Münster, was searched for patients with HIV infection admitted between 1992 and 2004. Their charts were reviewed regarding all available sociodemographic, clinical, neurophysiological, imaging and laboratory data, therapy and outcome. Stage of infection according to the CDC classification and the epileptogenic zone were determined.ResultsOf 831 HIV-infected patients treated in our department, 51 (6.1%) had seizures or epilepsy. Three of the 51 patients (6%) were diagnosed with epilepsy before the onset of the HIV infection. Fourteen patients (27%) only had single or few provoked seizures in the setting of acute cerebral disorders (eight patients), drug withdrawal or sleep withdrawal (two patients), or of unknown cause (four patients). Thirty-four patients (67%) developed epilepsy in the course of their HIV infection. Toxoplasmosis (seven patients), progressive multifocal leukencephalopathy (seven patients) and other acute or subacute cerebral infections (five patients) were the most frequent causes of seizures. EEG data of 38 patients were available. EEG showed generalized and diffuse slowing only in 9 patients, regional slowing in 14 patients and regional slowing and epileptiform discharges in 1 patient. Only 14 of the patients had normal EEG. At the last contact, the majority of the patients (46 patients = 90%) were on highly active antiretroviral therapy (HAART). Twenty-seven patients (53%) were on anticonvulsant therapy (gabapentin: 14 patients, carbamazepine: 9 patients, valproate: 2 patients, phenytoin: 1 patient, lamotrigine: 1 patient). Patients with only provoked seizures had no epilepsy risk factors except HIV infection, and were less likely to be infected via intravenous drug abuse.ConclusionsSeizures are a relevant neurological symptom during the course of HIV infection. Although in some patients seizures only occur provoked by acute disease processes, the majority of patients with new onset seizures eventually develops epilepsy and require anticonvulsant therapy. Intravenous drug abuse and the presence of non-HIV-associated risk factors for epilepsy seem to be associated with the development of chronic seizures in this patient group. Infection with the human immunodeficiency virus (HIV) is associated both with infections of the central nervous system and with neurological deficits due to direct effects of the neurotropic virus. Seizures and epilepsy are not rare among HIV-infected patients. We investigated the frequency of acute seizures and epilepsy of patients in different stages of HIV infection. In addition, we compared the characteristics of patients who experienced provoked seizures only with those of patients who developed epilepsy. The database of the Department of Neurology, University of Münster, was searched for patients with HIV infection admitted between 1992 and 2004. Their charts were reviewed regarding all available sociodemographic, clinical, neurophysiological, imaging and laboratory data, therapy and outcome. Stage of infection according to the CDC classification and the epileptogenic zone were determined. Of 831 HIV-infected patients treated in our department, 51 (6.1%) had seizures or epilepsy. Three of the 51 patients (6%) were diagnosed with epilepsy before the onset of the HIV infection. Fourteen patients (27%) only had single or few provoked seizures in the setting of acute cerebral disorders (eight patients), drug withdrawal or sleep withdrawal (two patients), or of unknown cause (four patients). Thirty-four patients (67%) developed epilepsy in the course of their HIV infection. Toxoplasmosis (seven patients), progressive multifocal leukencephalopathy (seven patients) and other acute or subacute cerebral infections (five patients) were the most frequent causes of seizures. EEG data of 38 patients were available. EEG showed generalized and diffuse slowing only in 9 patients, regional slowing in 14 patients and regional slowing and epileptiform discharges in 1 patient. Only 14 of the patients had normal EEG. At the last contact, the majority of the patients (46 patients = 90%) were on highly active antiretroviral therapy (HAART). Twenty-seven patients (53%) were on anticonvulsant therapy (gabapentin: 14 patients, carbamazepine: 9 patients, valproate: 2 patients, phenytoin: 1 patient, lamotrigine: 1 patient). Patients with only provoked seizures had no epilepsy risk factors except HIV infection, and were less likely to be infected via intravenous drug abuse. Seizures are a relevant neurological symptom during the course of HIV infection. Although in some patients seizures only occur provoked by acute disease processes, the majority of patients with new onset seizures eventually develops epilepsy and require anticonvulsant therapy. Intravenous drug abuse and the presence of non-HIV-associated risk factors for epilepsy seem to be associated with the development of chronic seizures in this patient group." @default.
• W2048201822 created "2016-06-24" @default.
• W2048201822 creator A5019458178 @default.
• W2048201822 creator A5026030959 @default.
• W2048201822 creator A5031379636 @default.
• W2048201822 creator A5034823471 @default.
• W2048201822 creator A5039052962 @default.
• W2048201822 creator A5041337719 @default.
• W2048201822 creator A5041969825 @default.
• W2048201822 creator A5065525659 @default.
• W2048201822 creator A5079897125 @default.
• W2048201822 creator A5084565202 @default.
• W2048201822 creator A5089470147 @default.
• W2048201822 date "2008-01-01" @default.
• W2048201822 modified "2023-10-06" @default.
• W2048201822 title "Frequency of seizures and epilepsy in neurological HIV-infected patients" @default.
• W2048201822 cites W179330255 @default.
• W2048201822 cites W1967986271 @default.
• W2048201822 cites W1971229520 @default.
• W2048201822 cites W1975846010 @default.
• W2048201822 cites W1996604523 @default.
• W2048201822 cites W2007751226 @default.
• W2048201822 cites W2025260112 @default.
• W2048201822 cites W2031197667 @default.
• W2048201822 cites W2031306324 @default.
• W2048201822 cites W2034666554 @default.
• W2048201822 cites W2063158417 @default.
• W2048201822 cites W2066506506 @default.
• W2048201822 cites W2074996911 @default.
• W2048201822 cites W2092913531 @default.
• W2048201822 cites W2106679881 @default.
• W2048201822 cites W2115140539 @default.
• W2048201822 cites W2115665560 @default.
• W2048201822 cites W2132346139 @default.
• W2048201822 cites W2166861522 @default.
• W2048201822 cites W2323645815 @default.
• W2048201822 cites W2408710283 @default.
• W2048201822 cites W44613858 @default.
• W2048201822 doi "https://doi.org/10.1016/j.seizure.2007.05.017" @default.
• W2048201822 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17618132" @default.
• W2048201822 hasPublicationYear "2008" @default.
• W2048201822 type Work @default.
• W2048201822 sameAs 2048201822 @default.
• W2048201822 citedByCount "92" @default.
• W2048201822 countsByYear W20482018222012 @default.
• W2048201822 countsByYear W20482018222013 @default.
• W2048201822 countsByYear W20482018222014 @default.
• W2048201822 countsByYear W20482018222015 @default.
• W2048201822 countsByYear W20482018222016 @default.
• W2048201822 countsByYear W20482018222017 @default.
• W2048201822 countsByYear W20482018222018 @default.
• W2048201822 countsByYear W20482018222019 @default.
• W2048201822 countsByYear W20482018222020 @default.
• W2048201822 countsByYear W20482018222021 @default.
• W2048201822 countsByYear W20482018222022 @default.
• W2048201822 countsByYear W20482018222023 @default.
• W2048201822 crossrefType "journal-article" @default.
• W2048201822 hasAuthorship W2048201822A5019458178 @default.
• W2048201822 hasAuthorship W2048201822A5026030959 @default.
• W2048201822 hasAuthorship W2048201822A5031379636 @default.
• W2048201822 hasAuthorship W2048201822A5034823471 @default.
• W2048201822 hasAuthorship W2048201822A5039052962 @default.
• W2048201822 hasAuthorship W2048201822A5041337719 @default.
• W2048201822 hasAuthorship W2048201822A5041969825 @default.
• W2048201822 hasAuthorship W2048201822A5065525659 @default.
• W2048201822 hasAuthorship W2048201822A5079897125 @default.
• W2048201822 hasAuthorship W2048201822A5084565202 @default.
• W2048201822 hasAuthorship W2048201822A5089470147 @default.
• W2048201822 hasBestOaLocation W20482018221 @default.
• W2048201822 hasConcept C118552586 @default.
• W2048201822 hasConcept C129692064 @default.
• W2048201822 hasConcept C16568411 @default.
• W2048201822 hasConcept C187212893 @default.
• W2048201822 hasConcept C203014093 @default.
• W2048201822 hasConcept C2778186239 @default.
• W2048201822 hasConcept C3013748606 @default.
• W2048201822 hasConcept C522805319 @default.
• W2048201822 hasConcept C71924100 @default.
• W2048201822 hasConceptScore W2048201822C118552586 @default.
• W2048201822 hasConceptScore W2048201822C129692064 @default.
• W2048201822 hasConceptScore W2048201822C16568411 @default.
• W2048201822 hasConceptScore W2048201822C187212893 @default.
• W2048201822 hasConceptScore W2048201822C203014093 @default.
• W2048201822 hasConceptScore W2048201822C2778186239 @default.
• W2048201822 hasConceptScore W2048201822C3013748606 @default.
• W2048201822 hasConceptScore W2048201822C522805319 @default.
• W2048201822 hasConceptScore W2048201822C71924100 @default.
• W2048201822 hasIssue "1" @default.
• W2048201822 hasLocation W20482018221 @default.
• W2048201822 hasLocation W20482018222 @default.
• W2048201822 hasOpenAccess W2048201822 @default.
• W2048201822 hasPrimaryLocation W20482018221 @default.
• W2048201822 hasRelatedWork W2002272356 @default.
• W2048201822 hasRelatedWork W2101002011 @default.
• W2048201822 hasRelatedWork W2419209382 @default.
• W2048201822 hasRelatedWork W2584059828 @default.
• W2048201822 hasRelatedWork W2607149964 @default.
• W2048201822 hasRelatedWork W3033904431 @default.

• next